Allergic rhinoconjunctivitis with or without asthma due to clinically relevant sensitisation to grass and olive pollen. research hub

Clinical trial to evaluate the efficacy and safety of Depigoid DUO Grass-Mix/Olea (1000 DPP/mL + 1000 DPP/mL) compared with placebo in patients suffering from allergic rhinoconjunctivitis with or without asthma due to clinically relevant sensitisation to grass and olive pollen.

This study is testing a new treatment for hay fever and eye allergies caused by grass and olive pollen, which might also help people with asthma. It compares the new treatment to a dummy treatment to see if it reduces symptoms and is safe.